Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SillyPoint
    Member
    • May 2008
    • 39

    #1

    ONT error model and quality scoring

    Regarding ONT's new technology, I think I heard the following over the last few days (please correct if I've mis-heard):
    • Error rate is 4% today, targeting 1% by release.
    • Predominant error is a deletion.
    • Output (e.g., from MinION) is in fastq format.

    4% of what? Given an error model including deletions, one possible interpretation is that there is a 4% chance that a given base will be missed. ONT, is that what you mean?

    More to the point: What observable aspects of the process are used in computing quality scores? We've been shown (sort of) how current traces can be converted into basecalls. What residue of that information is used in generating confidence estimates? If we knew that, we could better understand what use we can make of the scores.

    In any case, a fastq format doesn't seem appropriate. This isn't the Illumina error model, where you want to quantify by Q score the likelihood that a basecall at a given position is wrong. If I see a score of Q14 at some position in an ONT fastq file, does that mean there's a 4% chance that (1) the base was called wrong, (2) a base was missed following, or (3) prior to this position? How do I encode the case of miscall-plus-two-deletions at a given position?

    --TS

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...